FutureFuel (FF) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3 2024 revenue declined 56% year-over-year to $51.1M, with a net loss of $1.2M versus net income of $2.8M in Q3 2023, mainly due to lower biofuel sales volumes and prices.
For the nine months ended September 30, 2024, revenue fell 34% to $181.8M, net income was $12.7M (down 9%), and adjusted EBITDA dropped 28% to $13.0M.
Biofuel segment faced significant production issues, margin pressure from weak demand, lower RIN prices, and outages; chemical segment saw modest revenue changes but lower gross profit.
Cash and cash equivalents at September 30, 2024, were $133.4M, down from $219.4M at year-end 2023, mainly due to a $2.50/share special dividend.
Management expects cash, operating cash flow, and credit facility to be sufficient for operations and capital needs.
Financial highlights
Q3 2024 revenue: $51.1M (down $65.6M year-over-year); nine-month revenue: $181.8M (down $94.4M year-over-year).
Q3 2024 net loss: $1.2M; nine-month net income: $12.7M (down $1.3M year-over-year).
Q3 2024 adjusted EBITDA: $(1.0)M; nine-month adjusted EBITDA: $13.0M (down $5.2M year-over-year).
Gross profit for Q3 2024 was $0.4M, down from $3.9M in Q3 2023; nine-month gross profit was $14.0M, down from $16.9M.
Q3 operating loss: $2.9M versus $0.3M income last year; nine-month operating income: $4.8M (down 32%).
Outlook and guidance
Management anticipates margin and market uncertainty to persist until clarity on the IRA 45Z Clean Fuel Production Credit, effective January 2025.
Chemical segment expected to benefit from ongoing business development with key customers.
No material changes to previously disclosed risk factors; forward-looking statements caution on market and operational uncertainties.
Latest events from FutureFuel
- Annual meeting to elect directors, approve pay, and ratify auditor, with board size reduced.FF
Proxy filing - Q2 2026 saw revenue surge 121% and a return to profitability, driven by robust Chemicals and Biofuels growth.FF
Q2 2026 - Revenue up 82% year-over-year, but net loss widened on derivative and storm impacts.FF
Q1 2026 - 2025 saw steep losses and revenue declines, but new plant investments and regulatory clarity support a 2026 rebound.FF
Q4 2025 - Annual meeting to elect directors, ratify auditor, and update governance and compensation.FF
Proxy Filing - Shareholders will elect directors, ratify a new auditor, and see board and leadership changes.FF
Proxy Filing - Q3 2025 revenue dropped 56% with a $9.3M net loss amid biofuel market and regulatory headwinds.FF
Q3 2025 - Q2 2025 revenue fell 51% and net loss reached $10.4M as biodiesel production was idled.FF
Q2 2025 - Q2 net income reached $9.6M as margins improved despite lower revenue and market pressures.FF
Q2 2024